In pediatric sports medicine, it is now recognized that ACL injuries are increasingly common in kids. But their still-growing bodies present added risk when considering treatment options, not the least of which is the grueling recovery process following surgery to repair the injury. Dr. Mininder Kocher, associate professor of orthopaedic surgery at Harvard Medical School, and associate director of sports medicine at the Children's Hospital in Boston, assesses the relative risks of operative and non-operative treatment for ACL injuries in young athletes. How can we counsel our young patients who will not have surgery, but also refuse to adjust their activity level? Dr. Mark Nolan Hill hosts.
Relative Risks of ACL Repair in Young Athletes
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In pediatric sports medicine, it is now recognized that ACL injuries are increasingly common in kids. But their still-growing bodies present added risk when considering treatment options, not the least of which is the grueling recovery process following surgery to repair the injury. Dr. Mininder Kocher, associate professor of orthopaedic surgery at Harvard Medical School, and associate director of sports medicine at the Children's Hospital in Boston, assesses the relative risks of operative and non-operative treatment for ACL injuries in young athletes. How can we counsel our young patients who will not have surgery, but also refuse to adjust their activity level? Dr. Mark Nolan Hill hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
FINE-HEART Pooled Analysis
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?